DEXCOM INC Proceeds from Stock Issuance 2009-2026 | DXCM
Beta
What is DEXCOM INC's current proceeds from stock issuance?
DEXCOM INC (DXCM) annual proceeds from stock issuance for 2025 was $28.1M, a 0.35% decline from 2024. DEXCOM INC proceeds from stock issuance for the quarter ending March 31, 2026 was $12.7M.
What was DEXCOM INC's proceeds from stock issuance in 2024?
DEXCOM INC annual proceeds from stock issuance for 2024 was $28.2M, a 6.02% increase from 2023.
What was DEXCOM INC's proceeds from stock issuance in 2023?
DEXCOM INC annual proceeds from stock issuance for 2023 was $26.6M, a 18.22% increase from 2022.
What is DEXCOM INC's 5-year proceeds from stock issuance CAGR?
DEXCOM INC proceeds from stock issuance grew at a compound annual growth rate (CAGR) of 12.93% from FY2020 to FY2025, going from $15.3M to $28.1M over 5 years.
Proceeds from Stock Issuance History
Year-over-year comparison from 10-K annual reports
Key Statistics
Trend Direction
Stable
CAGR+12.9%
FY2020
$15.3M
→
FY2025
$28.1M
0910111213141516171819202122232425
5 years selected
Proceeds from Stock Issuance History
| Period | Value | Change | Source |
|---|---|---|---|
| FY2025 | $28.1M | -0.4% | 10-K |
| FY2024 | $28.2M | +6.0% | 10-K |
| FY2023 | $26.6M | +18.2% | 10-K |
| FY2022 | $22.5M | +10.8% | 10-K |
| FY2021 | $20.3M | +32.7% | 10-K |
| FY2020 | $15.3M | +28.6% | 10-K |
| FY2019 | $11.9M | +10.2% | 10-K |
| FY2018 | $10.8M | +6.9% | 10-K |
| FY2017 | $10.1M | -2.9% | 10-K |
| FY2016 | $10.4M | -45.5% | 10-K |
| FY2015 | $19.1M | -20.4% | 10-K |
| FY2014 | $24.0M | +100.0% | 10-K |
| FY2013 | $12.0M | +233.3% | 10-K |
| FY2012 | $3.6M | -95.2% | 10-K |
| FY2011 | $74.7M | +6.0% | 10-K |
| FY2010 | $70.5M | +52.2% | 10-K |
| FY2009 | $46.3M | - | 10-K |
Company: DEXCOM INCTicker: DXCMSector: HealthcareIndustry: Surgical & Medical Instruments & ApparatusView company profile →